Literature DB >> 26002716

Dynamic changes in plasma tissue plasminogen activator, plasminogen activator inhibitor-1 and beta-thromboglobulin content in ischemic stroke.

Ping Zhuang1, Da Wo2, Zeng-Guang Xu2, Wei Wei2, Hui-ming Mao3.   

Abstract

The aim of this paper is to investigate the corresponding variations of plasma tissue plasminogen activator (t-PA) and plasminogen activator inhibitor-1 (PAI-1) activities, and beta-thromboglobulin (β-TG) content in patients during different stages of ischemic stroke. Ischemic stroke is a common disease among aging people and its occurrence is associated with abnormalities in the fibrinolytic system and platelet function. However, few reports focus on the dynamic changes in the plasma fibrinolytic system and β-TG content in patients with ischemic stroke. Patients were divided into three groups: acute, convalescent and chronic. Plasma t-PA and PAI-1 activities were determined by chromogenic substrate analysis and plasma β-TG content was detected by radioimmunoassay. Patients in the acute stage of ischemic stroke had significantly increased levels of t-PA activity and β-TG content, but PAI-1 activity was significantly decreased. Negative correlations were found between plasma t-PA and PAI-1 activities and between plasma t-PA activity and β-TG content in patients with acute ischemic stroke. There were significant differences in plasma t-PA and PAI-1 activities in the aged control group, as well as in the acute, convalescent and chronic groups. It can be speculated that the increased activity of t-PA in patients during the acute stage was the result of compensatory function, and that the increase in plasma β-TG level not only implies the presence of ischemic stroke but is likely a cause of ischemic stroke. During the later stages of ischemic stroke, greater attention is required in monitoring levels of PAI-1.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Beta–thromboglobulin; Ischemic stroke; Plasma; Plasminogen activator inhibitor-1; Tissue plasminogen activator

Mesh:

Substances:

Year:  2015        PMID: 26002716     DOI: 10.1016/j.jocn.2014.12.027

Source DB:  PubMed          Journal:  J Clin Neurosci        ISSN: 0967-5868            Impact factor:   1.961


  2 in total

1.  Plasminogen activator inhibitor-1 augments damage by impairing fibrinolysis after traumatic brain injury.

Authors:  Eva-Verena Griemert; Susanne M Schwarzmaier; Regina Hummel; Christina Gölz; Dong Yang; Winfried Neuhaus; Malgorzata Burek; Carola Y Förster; Ivan Petkovic; Raimund Trabold; Nikolaus Plesnila; Kristin Engelhard; Michael K Schäfer; Serge C Thal
Journal:  Ann Neurol       Date:  2019-03-30       Impact factor: 10.422

2.  "Case series: ischemic stroke associated with dehydration and arteriosclerosis in individuals with severe anorexia nervosa".

Authors:  Yu Mimura; Yusuke Shimizu; Hiroki Oi; Shin Kurose; Shun Kudo; Taketo Takata; Masaru Mimura; Michitaka Funayama
Journal:  J Eat Disord       Date:  2021-03-20
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.